Edit

About Us

Leader Healthcare Group is a part of Leader Global Group. Leader Global Group operates across the MENA, APAC & South Asia regions. A customer-centric network of corporate offices, distribution centers and strategic alliances across the globe supports the innovation and excellence initiatives of its stakeholders.

 

Contact Info

+971 4 3263980

Edit

About Us

Leader Healthcare Group is a part of Leader Global Group. Leader Global Group operates across the MENA, APAC & South Asia regions. A customer-centric network of corporate offices, distribution centers and strategic alliances across the globe supports the innovation and excellence initiatives of its stakeholders.

 

Contact Info

+971 4 3263980

SmartVest HFCWO Therapy: A Medical Endowment Advocating Quality Respiratory Health

SmartVest HFCWO Therapy: A Medical Endowment Advocating Quality Respiratory Health

Medical conditions associated with the lungs are widespread in the world. Occupational lung diseases, asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension are some of the more common ones. The airways and other lung structures are often affected by chronic respiratory diseases. Most Chronic Respiratory Diseases (CRD) are incurable. However, treatments are available to help cope with shortness of breath and dilate major airways. These treatments can also aid in improving the symptoms and quality of life for people with respiratory diseases.

No alt text provided for this image

During any lung disease, a matter of extreme importance is to effectively clear mucus from the air passages and the lungs. Pathogens are removed from the body by generating mucus. The mucus traps the pathogens so that they cannot reach the lining of our lungs and airways. In addition, a sweeping action of tiny hair-like particles called cilia is functional in the lower respiratory tract of the lungs. It helps to mobilize mucus along with the irritants, up and out of the lungs and breathing passageways. As mucus builds up, nerve sensors in the body activate, causing a cough that helps remove excess mucus. Mucus can become very dense and thick in your lungs when chest congestion issues. As a result, coughing can become difficult.

No alt text provided for this image

The use of manual chest physiotherapy or HFCWO vest therapy can improve both pulmonary function and quality of life in patients with chronic hypersecretory diseases. The primary purpose of HFCWO treatment is to irradicate infections and improve patients’ quality of life by sheering away solidified secretions. In addition, the process facilitates the breaking up of mucus in the lungs and bronchioles to be coughed out or suctioned out through the upper airways- mouth and nose.

HFCWO devices consist of an inflatable vest that is connected to an external generator, which is used to deliver percussion to the chest wall. Repeated pulses of positive air pressure are applied to the chest to facilitate mucus clearance. The therapy should be administered only after a doctor’s approval and the procedure is often performed by inculcating bronchodilator drugs that help dilate bronchioles. Every person receives different levels of pressure and frequency. They are increased at low pressure until a recommended level is reached. Treatment sessions usually last for 30 minutes while the patient is upright. To cough out the mucus that has loosened and moved into the large airways, pauses are taken.

No alt text provided for this image

The SmartVest airway clearance system is an effective airway clearance system devised for people with various lung disorders. This electronic device is formulated to deliver high-energy oscillations to the chest wall to alleviate bronchial drainage for people suffering from cystic fibrosis, cerebral palsy, and other disease conditions that cause blockages in the lungs.

SmartVest eliminates the expense and dependence of a care provider. The treatment can be done without the help and does not require any skill. SmartVest also guarantees maximum liberty for the patient during treatment because no particular position or breathing techniques are needed. Fast-paced treatment is an added advantage of the device as it treats all lung lobes at once.

No alt text provided for this image

The SmartVest has a compact structure that is designed to maximize comfort. The vest wear comes with a tailor-fit design where the garment contours to the chest and pulse attitude remain constant during the inhalation and escalation. The vest garment is fashioned in such a way that it can be attached to Velcro-like closures. Besides, the vest wear provides 360-degree coverage to the torso, ensuring effective treatment. The device is ingrained with an easy-to-use interface and accident prevention lock. The single hose system of the SmartVest makes it more adaptable and the feature of all-time consistent bias pressure boosts the comfort.

No alt text provided for this image

Unique and patented features of the portable air-pulse generator are designed to enhance ergonomic comfort and lifestyle convenience, so patients can get better by doing therapy more efficiently and consistently. SmartVest’s air pulse generator transmits air pulses to the chest via the connection hose and vest. The generator is designed to operate in either the upright or horizontal position.

No alt text provided for this image

Reports from the satisfied users of SmartVest ascertain that the device is more cost-effective than standard HFWCO devices. A study of 59 SmartVest patients with non-cystic fibrosis bronchiectasis was conducted to estimate cost-effectiveness. This outcomes study demonstrated that using the SmartVest system for one year resulted in 57% fewer antibiotic prescriptions, a 60% decrease in emergency department visits, and a 58% decrease in the total number of hospitalizations per the study population. As a result, patients reported a 68% quality of life improvement. In addition, the study results revealed an annual savings of $3,045 per bronchiectasis patient per year of SmartVest use.

The makers of SmartVest take pride in the fact that 59% of exacerbations requiring hospitalization were reduced with SmartVest in 2016. Moreover, SmartVest demonstrated improved symptom scores and quality of life, and ED visits were significantly reduced with SmartVest.

No alt text provided for this image

Lung care is complex and costly. Conventional methods no longer meet the needs of today’s patients, providers and biopharma innovators. Leader Healthcare understands the changing need of people with lung complications and hence our solutions are uniquely efficient, affordable and accessible at the same time. If you are interested in many of our such solutions, reach out to us at helpdesk@leaderhealthcare group.com or visit our website www.leaderhealthcaregroup.com for more info!

Leave a Reply

Your email address will not be published.

Committed To Transforming Healthcare

Copyright © 2021 Leader Healthcare Group All Rights Reserved